Skip to content

Clinical trials

Completed Phase 3 Cardiomyopathies trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathies Phase: Phase 3 Status: Completed Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20031
20042
20092
20101
20122
20131
20141
20171
20192
20204

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Scios, Inc.5
Alnylam Pharmaceuticals2
Assistance Publique - Hôpitaux de Paris1
Corewell Health East1
Eidos Therapeutics, a BridgeBio company1
I.M. Sechenov First Moscow State Medical University1
Ionis Pharmaceuticals, Inc.1
M.p. van den Berg, MD, PhD, professor in Cardiology1
Mallinckrodt1
Mayo Clinic1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathies23
Heart Failure11
Renal Insufficiency6
Amyloidosis4
Heart Diseases3
Alzheimer Disease2
Amyloid Neuropathies, Familial2
Dyspnea, Paroxysmal2
Acute Lung Injury1
Amyloid Neuropathies1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.